-
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart FailureMehra MR, Goldstein DJ, MOMENTUM 3 Investigators. -
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REALCavender MA, Norhammar A, CVD-REAL Investigators and Study Group.
-
Titration of Medical Therapy for Heart Failure With Reduced Ejection FractionSJ Greene, GC Fonarow, AD DeVore et al.
-
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"JG Howlett.
-
Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia BurdenS Tankut, I Goldenberg, V Kutyifa et al.
-
Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and ManagementA Pandey, D Kitzman, G Reeves.
-
Nitrosative stress drives heart failure with preserved ejection fractionSchiattarella GG, Altamirano F, Hill JA et al.
-
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart FailureCK Nagaraju, EL Robinson, KR Sipido et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
